Your shopping cart is currently empty

Utibapril, an inhibitor of angiotensin-converting enzyme (ACE), exhibits antihypertensive activities.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | Utibapril, an inhibitor of angiotensin-converting enzyme (ACE), exhibits antihypertensive activities. |
| In vivo | Utibapril significantly inhibits plasma, renal, and vascular ACE but not ventricular ACE activity. Vascular ACE activity is significantly inhibited by Utibapril (2 μg/kg/day), and Utibapril (250 μg/kg/day) results in significant inhibition of plasma ACE. Additionally, angiotensin I-induced decreases in coronary flow in the isolated heart are significantly inhibited after treatment with higher doses of Utibapril [1]. FPL 63547 is rapidly and extensively excreted as the diacid in bile but appears in urine in negligible amounts [2]. |
| Synonyms | FPL 63547 |
| Molecular Weight | 449.56 |
| Formula | C22H31N3O5S |
| Cas No. | 109683-61-6 |
| Smiles | C([C@@H](N[C@@H](CCC1=CC=CC=C1)C(OCC)=O)C)(=O)N2[C@H](C(O)=O)SC(C(C)(C)C)=N2 |
| Relative Density. | 1.24g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.